| For: | Yamagiwa S, Kamimura H, Takamura M, Aoyagi Y. Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance. World J Gastroenterol 2014; 20(10): 2606-2612 [PMID: 24627596 DOI: 10.3748/wjg.v20.i10.2606] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i10/2606.htm |
| Number | Citing Articles |
| 1 |
Paschalis Chatzipantelis, Alexandra Giatromanolaki. Early histopathologic changes in primary biliary cholangitis: does ‘minimal change’ primary biliary cholangitis exist? A pathologist’s view. European Journal of Gastroenterology & Hepatology 2021; 33(12) doi: 10.1097/MEG.0000000000001876
|
| 2 |
Alicja Bauer, Andrzej Habior, Damian Gawel. Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines 2022; 10(4) doi: 10.3390/biomedicines10040801
|
| 3 |
Ahmad H. Ali, James H. Tabibian, Elizabeth J. Carey, Keith D. Lindor. Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert Opinion on Emerging Drugs 2016; 21(1) doi: 10.1517/14728214.2016.1150999
|
| 4 |
Hyun Jin Cha, Jimin Hwang, Lucy Eunju Lee, Younhee Park, Jason Jungsik Song, Gianfranco D. Alpini. The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease. PLOS ONE 2021; 16(1) doi: 10.1371/journal.pone.0244950
|
| 5 |
Øystein Fluge, Olav Mella, Ove Bruland, Kristin Risa, Sissel E. Dyrstad, Kine Alme, Ingrid G. Rekeland, Dipak Sapkota, Gro V. Røsland, Alexander Fosså, Irini Ktoridou-Valen, Sigrid Lunde, Kari Sørland, Katarina Lien, Ingrid Herder, Hanne Thürmer, Merete E. Gotaas, Katarzyna A. Baranowska, Louis M.L.J. Bohnen, Christoph Schäfer, Adrian McCann, Kristian Sommerfelt, Lars Helgeland, Per M. Ueland, Olav Dahl, Karl J. Tronstad. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight 2016; 1(21) doi: 10.1172/jci.insight.89376
|
| 6 |
Zeineb Zian, S.P. Déo-Gracias Berry, Nazila Bahmaie, Dana Ghotbi, Ali Kashif, Manisha Madkaikar, Umair Ahmed Bargir, Hamisu Abdullahi, Haroon Khan, Gholamreza Azizi. The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies. International Immunopharmacology 2021; 95 doi: 10.1016/j.intimp.2021.107565
|
| 7 |
Yuxin Liu, Jianghong Yu, Zachary Oaks, Ivan Marchena-Mendez, Lisa Francis, Eduardo Bonilla, Phillip Aleksiejuk, Jessica Patel, Katalin Banki, Steve K. Landas, Andras Perl. Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clinical Immunology 2015; 160(2) doi: 10.1016/j.clim.2015.07.001
|
| 8 |
Caterina Maria Gambino, Luisa Agnello, Vincenza Calvaruso, Rosaria Vincenza Giglio, Luigi Capodicasa, Concetta Scazzone, Giuseppina Candore, Fabio Del Ben, Vito Di Marco, Marcello Ciaccio. Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience. Clinica Chimica Acta 2025; 566 doi: 10.1016/j.cca.2024.120037
|
| 9 |
. 2022; doi: 10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
|
| 10 |
Henry H. Nguyen, Abdel Aziz Shaheen, Natalia Baeza, Ellina Lytvyak, Stefan J. Urbanski, Andrew L. Mason, Gary L. Norman, Marvin J. Fritzler, Mark G. Swain, Gianfranco D. Alpini. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS). PLOS ONE 2018; 13(3) doi: 10.1371/journal.pone.0193960
|
| 11 |
I. Franco, A. Dubini, S. Piciucchi, G. Casoni, V. Poletti. Interstitial lung disease preceding primary biliary cirrhosis in a male patient. Revista Portuguesa de Pneumologia (English Edition) 2015; 21(4) doi: 10.1016/j.rppnen.2015.02.008
|
| 12 |
Ralf Weiskirchen, Sabine Weiskirchen, Frank Tacke. Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Research 2018; 7 doi: 10.12688/f1000research.14841.1
|
| 13 |
B. D. Chaltsev, V. I. Vasilyev, S. G. Palshina, A. V. Torgashina, E. V. Sokol, Yu. I. Khvan, T. N. Safonova, E. V. Rodionova, I. V. Gaiduk, L. L. Borozdkin. CLINICAL AND LABORATORY FEATURES OF ANTICENTROMERE ANTIBODY-POSITIVE SJö GREN’S SYNDROME. Rheumatology Science and Practice 2019; 57(4) doi: 10.14412/1995-4484-2019-431-439
|
| 14 |
Won-Tak Choi, Ryan M. Gill. Pathologic features and differential diagnosis of chronic hepatitis. Diagnostic Histopathology 2023; 29(1) doi: 10.1016/j.mpdhp.2022.10.003
|
| 15 |
Tingwang Jiang, Xiaoli Xiang, Xudong Wang, Zhijun Han, Cuie Cheng, Yuehong Zhu, Zaixing Yang, Yan Liang. Regulatory T Cells and Autoimmune Diseases. 2024; doi: 10.1016/B978-0-443-13947-5.00014-2
|
| 16 |
Alessandro P. Delitala, Giovanni M. Pes, Giuseppe Fanciulli, Margherita Maioli, Giannina Secchi, Franca Sanciu, Giuseppe Delitala, Roberto Manetti. Organ-specific antibodies in LADA patients for the prediction of insulin dependence. Endocrine Research 2016; 41(3) doi: 10.3109/07435800.2015.1136934
|
| 17 |
Melissa Palmer, Arie Regev, Keith Lindor, Mark I. Avigan, Lara Dimick‐Santos, William Treem, John F. Marcinak, James H. Lewis, Frank A. Anania, Daniel Seekins, Benjamin L. Shneider, Naga Chalasani. Consensus guidelines: best practices for detection, assessment and management of suspected acute drug‐induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease. Alimentary Pharmacology & Therapeutics 2020; 51(1) doi: 10.1111/apt.15579
|
| 18 |
Francesca Colapietro, Ana Lleo, Elena Generali. Antimitochondrial Antibodies: from Bench to Bedside. Clinical Reviews in Allergy & Immunology 2021; 63(2) doi: 10.1007/s12016-021-08904-y
|
| 19 |
Alicja Bauer, Andrzej Habior. Detection of Autoantibodies Against Nucleoporin p62 in Sera of Patients With Primary Biliary Cholangitis. Annals of Laboratory Medicine 2019; 39(3) doi: 10.3343/alm.2019.39.3.291
|
| 20 |
Tiannan Zhou, Huixian Wei, Jinjun Wang, Sudhir Kumar Rai. Research experimental design for the construction and identification of the pGEX-BCKD-E4A recombinant point-mutant plasmid. PLOS ONE 2023; 18(2) doi: 10.1371/journal.pone.0279431
|
| 21 |
Kazuki Shimojo, Itsuro Morishima, Yasuhiro Morita, Yasunori Kanzaki, Naoki Watanabe, Naoki Yoshioka, Naoki Shibata, Yoshihito Arao, Hoshito Karasawa, Yuta Nakagawa, Yuki Kawasaki, Tatsuki Yoshie. Impact of Anti-Mitochondrial Antibody Positivity on Isolated Cardiac Involvement: A Pilot Study Focusing on the Right Atrial Low Voltage Area and Sick Sinus Syndrome. Internal Medicine 2026; doi: 10.2169/internalmedicine.7248-26
|
| 22 |
Elisabet Poyatos, Francisco Morandeira, Joan Climent, Virginia Mas, José Castellote, Jordi Bas. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis. Clinical Immunology 2024; 268 doi: 10.1016/j.clim.2021.108749
|
| 23 |
Albert Parés. Practical management of primary biliary cholangitis. Revista Española de Enfermedades Digestivas 2021; doi: 10.17235/reed.2021.8219/2021
|
| 24 |
Ji-Won Park, Jung-Hee Kim, Sung-Eun Kim, Jang Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Hyoung-Su Kim, Ki Tae Suk, Dong Joon Kim. Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines 2022; 10(6) doi: 10.3390/biomedicines10061288
|
| 25 |
Olwyn Byron, John Gordon Lindsay. Macromolecular Protein Complexes. Subcellular Biochemistry 2017; 83 doi: 10.1007/978-3-319-46503-6_19
|
| 26 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. An Integrated Pathogenetic Model of Primary Biliary Cholangitis. Livers 2025; 5(2) doi: 10.3390/livers5020015
|
| 27 |
Raj A Shah, Kris V Kowdley. Current and potential treatments for primary biliary cholangitis. The Lancet Gastroenterology & Hepatology 2020; 5(3) doi: 10.1016/S2468-1253(19)30343-7
|
| 28 |
|
| 29 |
Wei Huang, Tianyu Jin, Wei Zheng, Qiaoqiao Yin, Qiqi Yan, Hongying Pan, Chengan Xu. Identifying the genetic association between systemic lupus erythematosus and the risk of autoimmune liver diseases. Journal of Autoimmunity 2024; 145 doi: 10.1016/j.jaut.2024.103188
|
| 30 |
Naoki Takahashi, Takako Saeki, Atsushi Komatsuda, Chishio Munemura, Takeaki Fukui, Naofumi Imai, Noriyuki Homma, Tsuguru Hatta, Ken-ichi Samejima, Takashi Fujimoto, Hiroki Omori, Yumi Ito, Yudai Nishikawa, Mamiko Kobayashi, Yukie Morikawa, Sachiko Fukushima, Seiji Yokoi, Daisuke Mikami, Kenji Kasuno, Hideki Kimura, Tomoyuki Nemoto, Yasunari Nakamoto, Kiyonao Sada, Manabu Sugai, Hironobu Naiki, Haruyoshi Yoshida, Ichiei Narita, Yoshihiko Saito, Masayuki Iwano. Tubulointerstitial Nephritis with IgM-Positive Plasma Cells. Journal of the American Society of Nephrology 2017; 28(12) doi: 10.1681/ASN.2016101074
|
| 31 |
Hannah Klatzkow, Indira Bhavsar-Burke, Meredith Pearson, Brian J. Wentworth. Primary Biliary Cholangitis in 2025: A New Frontier. American Journal of Gastroenterology 2025; 120(12) doi: 10.14309/ajg.0000000000003559
|
| 32 |
Wen-Tao Ma, De-Kun Chen. Immunological abnormalities in patients with primary biliary cholangitis. Clinical Science 2019; 133(6) doi: 10.1042/CS20181123
|
| 33 |
Valentina Guatibonza-García, Paula Valentina Gaete, Agustín Pérez-Londoño, Danna Kathalina Puerto-Baracaldo, Sebastián Antonio Gutiérrez-Romero, Carlos O Mendivil, Monica Tapias. Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study. World Journal of Gastroenterology 2021; 27(29): 4890-4899 doi: 10.3748/wjg.v27.i29.4890
|
| 34 |
MINORU TOMIZAWA, FUMINOBU SHINOZAKI, KAZUNORI FUGO, YASUFUMI MOTOYOSHI, TAKAO SUGIYAMA, SHIGENORI YAMAMOTO, TAKASHI KISHIMOTO, NAOKI ISHIGE. Anti-mitochondrial M2 antibody-positive autoimmune hepatitis. Experimental and Therapeutic Medicine 2015; 10(4) doi: 10.3892/etm.2015.2694
|
| 35 |
Treta Purohit, Mitchell S Cappell. Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy. World Journal of Hepatology 2015; 7(7): 926-941 doi: 10.4254/wjh.v7.i7.926
|
| 36 |
Hao Li, Yanling Guan, Chenchen Han, Yu Zhang, Qian Liu, Wei Wei, Yang Ma. The pathogenesis, models and therapeutic advances of primary biliary cholangitis. Biomedicine & Pharmacotherapy 2021; 140 doi: 10.1016/j.biopha.2021.111754
|
| 37 |
Ying-Qiu Huang. Recent advances in the diagnosis and treatment of primary biliary cholangitis. World Journal of Hepatology 2016; 8(33): 1419-1441 doi: 10.4254/wjh.v8.i33.1419
|
| 38 |
Wei Zhang, Jung-hyun Rho, Michael H. Roehrl, Julia Y. Wang. A comprehensive autoantigen-ome of autoimmune liver diseases identified from dermatan sulfate affinity enrichment of liver tissue proteins. BMC Immunology 2019; 20(1) doi: 10.1186/s12865-019-0304-1
|
| 39 |
Alexander J. Kovalic, Herbert L. Bonkovsky. Diagnosis and Management of Autoimmune Hepatitis. 2020; doi: 10.1007/978-3-030-33628-8_2
|
| 40 |
Francesco Martini, Daniele Balducci, Martina Mancinelli, Valerio Buzzanca, Elena Fracchia, Giuseppe Tarantino, Antonio Benedetti, Marco Marzioni, Luca Maroni. Risk Stratification in Primary Biliary Cholangitis. Journal of Clinical Medicine 2023; 12(17) doi: 10.3390/jcm12175713
|
| 41 |
Yadan Li, Guangzhi Xiao, Rongrong Dou, Hao Liu, Jin Ding, Zhaohui Zheng. Anti-centromere antibody positivity: a spectrum of clinical diagnoses and immunological patterns in a large patient cohort. Clinical Rheumatology 2026; 45(10) doi: 10.1007/s10067-026-08355-w
|
| 42 |
Emina Halilbasic, Elisabeth Tatscher, Elmar Aigner, Lukas Burghart, Ivo Graziadei, Stephanie Hametner-Schreil, Benedikt Silvester Hofer, Harald Hofer, Andreas Maieron, Mattias Mandorfer, Markus Peck-Radosavljevic, Benedikt Schaefer, Wolfgang Sieghart, Martin Stradner, Stefan Traussnigg, Martin Wagner, Heinz Zoller, Peter Fickert, Michael Trauner. Austrian Society of Gastroenterology and Hepatology (ÖGGH) consensus on primary biliary cholangitis. Wiener klinische Wochenschrift 2026; 138(S13) doi: 10.1007/s00508-026-02798-6
|
| 43 |
Evolving paradigms in primary biliary cholangitis: from molecular mechanisms to personalized therapeutics with seladelpar, elafibranor, and beyond. Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00464-6
|
| 44 |
Shirley R. R. Utiyama, Katiane B. Zenatti, Heloisa A. J. Nóbrega, Juliana Z. C. Soares, Thelma L. Skare, Caroline Matsubara, Dominique A. Muzzilo, Renato M. Nisihara. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases. Immunological Investigations 2016; 45(6) doi: 10.1080/08820139.2016.1186173
|
| 45 |
Qian Zhang, Zhiqiang Liu, Shanshan Wu, Weijia Duan, Sha Chen, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia. Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis. Gastroenterology Research and Practice 2019; 2019 doi: 10.1155/2019/8959103
|
| 46 |
Eszter Szabo, Balint Nagy, Andras Czajlik, Timea Komlodi, Oliver Ozohanics, Laszlo Tretter, Attila Ambrus. Macromolecular Protein Complexes V. Subcellular Biochemistry 2024; 104 doi: 10.1007/978-3-031-58843-3_13
|
| 47 |
Christopher Chang, Atsushi Tanaka, M. Eric Gershwin. Unmet needs in autoimmune liver diseases. Journal of Digestive Diseases 2019; 20(7) doi: 10.1111/1751-2980.12785
|
| 48 |
Natalia M. Krajewska, Rémi Fiancette, Ye H. Oo. Interplay between Mast Cells and Regulatory T Cells in Immune-Mediated Cholangiopathies. International Journal of Molecular Sciences 2022; 23(11) doi: 10.3390/ijms23115872
|
| 49 |
Eunhee Han, Sung Jin Jo, Hyeyoung Lee, Ae-Ran Choi, Jihyang Lim, Eun-Sun Jung, Eun-Jee Oh. Clinical relevance of combined anti-mitochondrial M2 detection assays for primary biliary cirrhosis. Clinica Chimica Acta 2017; 464 doi: 10.1016/j.cca.2016.11.021
|
| 50 |
Sumio Minamiyama, Sakiho Ueda, Ran Nakashima, Hodaka Yamakado, Yusuke Sakato, Hirofumi Yamashita, Nobukatsu Sawamoto, Ryota Fujimoto, Ichizo Nishino, Makoto Urushitani, Tsuneyo Mimori, Ryosuke Takahashi. Thigh muscle MRI findings in myopathy associated with anti‐mitochondrial antibody. Muscle & Nerve 2020; 61(1) doi: 10.1002/mus.26731
|
| 51 |
Xiaoli Zeng, Siting Li, Shiyi Tang, Xi Li, Guoyuan Zhang, Mengtao Li, Xiaofeng Zeng, Chaojun Hu. Changes of Serum IgG Glycosylation Patterns in Primary Biliary Cholangitis Patients. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.669137
|
| 52 |
Alicja Bauer, Tomasz Rawa. Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021333
|
| 53 |
Lisa Florin, Kaat Rubben, Amber Vanhaecke, Katrien Devreese, Filip De Keyser, Vanessa Smith, Carolien Bonroy. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2020; 58(3) doi: 10.1515/cclm-2019-0655
|
| 54 |
Klairi Papachristou, Maria Angelara, Konstantinos Manganas, Theodoros Androutsakos. Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review. International Journal of Molecular Sciences 2026; 27(3) doi: 10.3390/ijms27031388
|